Loading...
Polymeric Nanohybrids as a New Class of Therapeutic Biotransporters
Whitlow, Jonathan Pacelli, Settimio Paul, Arghya
Whitlow, Jonathan
Pacelli, Settimio
Paul, Arghya
Citations
Altmetric:
Abstract
A possible solution to enhance existing drug and gene therapies is to develop hybrid nanocarriers capable of delivering therapeutic agents in a controlled and targeted manner. This goal can be achieved by designing nanohybrid systems, which combine organic or inorganic nanomaterials with biomacromolecules into a single composite. The unique combination of properties along with their facile fabrication enables the design of smart carriers for both drug and gene delivery. These hybrids can be further modified with cell targeting motifs to enhance their biological interactivity. In this Talents and Trends article, an overview of emerging nanohybrid-based technologies will be provided to highlight their potential use as innovative platforms for improved cancer therapies and new strategies in regenerative medicine. The clinical relevance of these systems will be reviewed to define the current challenges which still need to be addressed to allow these therapies to move from bench to bedside.
Description
This is the peer reviewed version of the following article: Macromol Chem Phys. 2016 Jun; 217(11): 1245–1259., which has been published in final form at http://doi.org/10.1002/macp.201500464. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Date
2016-06
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Research Projects
Organizational Units
Journal Issue
Keywords
Biomaterials, Cardiovascular therapy, Medical devices, Nanomedicine, Regenerative medicine
Citation
Whitlow, J., Pacelli, S., & Paul, A. (2016). Polymeric Nanohybrids as a New Class of Therapeutic Biotransporters. Macromolecular Chemistry and Physics, 217(11), 1245–1259. http://doi.org/10.1002/macp.201500464